Top news of the week: 19.05.2020.

#lifesciences #biotechnology #pharmaceuticals #biospace #CoronaPandemic #CoronaOutbreak #COVID19 #CoronaVirus #ArtificialIntelligence #dod

Career And Jobs

On May 18, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: May 18 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/g0nMrD7XyY
Open

Biopharma Update on the Novel Coronavirus: May 18

Biopharma Update on the Novel Coronavirus: May 18

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 18, 2020.

On May 12, 2020
@BiotechWorld shared
Next-gen biotech Caribou Biosciences nabs Array (now Pfizer) cancer R&D exec as clinical lead https://t.co/NA5oDdRGtW https://t.co/lTvA90kKbA
Open

Next-gen biotech Caribou Biosciences nabs Array (now Pfizer) cancer R&D exec as clinical lead

Next-gen biotech Caribou Biosciences nabs Array (now Pfizer) cancer R&D exec as clinical lead

After a relatively quiet few years, Caribou Biosciences has hired Cherry Thomas, M.D., as its new senior vice president of clinical development.

On May 14, 2020
@biospace shared
Legend Biotech Aims for $100 Million IPO #biospace #lifesciences #biotechnology #pharmaceuticals https://t.co/mN85jUcrUE
Open

Legend Biotech Aims for $100 Million IPO

Legend Biotech Aims for $100 Million IPO

Legend Biotech, a clinical stage oncology biotech company, filed with the U.S. Securities and Exchange Commission on Wednesday to raise up to $100 million in an initial public offering.

On May 18, 2020
@biospace shared
SQZ Biotech Raises $65 Million to Advance Cancer and Infectious Disease Programs #biospace #lifesciences #biotechnology #pharmaceuticals https://t.co/oPovXzSAaH
Open

SQZ Biotech Raises $65 Million to Advance Cancer and Infectious Disease Programs

SQZ Biotech Raises $65 Million to Advance Cancer and Infectious Disease Programs

“We are thrilled to have the support of both our new and long-standing investors who believe in SQZ and our potential to create impactful therapies for patients,” said Teri Loxam, SQZ’s ...

On May 14, 2020
@BiotechWorld shared
J&J-backed CAR-T biotech Legend guns for $100M IPO but sees CRS death in early trial https://t.co/4e40uJIuaE https://t.co/UpLNx5nJTg
Open

J&J-backed CAR-T biotech Legend guns for $100M IPO but sees CRS death in early trial

J&J-backed CAR-T biotech Legend guns for $100M IPO but sees CRS death in early trial

Legend Biotech is hoping it can ride the biotech IPO wave and take in a cool $100 million for its cell therapy work.

On May 15, 2020
@SynBioBeta shared
RT @Aanikabio: We are thrilled to have @1AlexanderTitus join our advisor board! https://t.co/I86M3u7hNt #synbio #ArtificialIntelligence #dod @BioeconomyXYZ @SynBioBeta
Open

Aanika Biosciences welcomes Dr. Alexander Titus, former Assistant Director of Biotechnology at the Department of Defense (DoD), to its Advisory Board

Aanika Biosciences welcomes Dr. Alexander Titus, former Assistant Director of Biotechnology at the Department of Defense (DoD), to its Advisory Board

At Aanika, we believe having a strong advisory board is just as important as building a top-notch core team. Our advisors have gone above…

On May 15, 2020
@JohnCendpts shared
Moncef Slaoui pivots from Moderna's board to the helm of Project Warp Speed. His task: Overnight success https://t.co/bFtNJsjT8Y
Open

Moncef Slaoui pivots from Moderna's board to the helm of Project Warp Speed. His task: Overnight success

Moncef Slaoui pivots from Moderna's board to the helm of Project Warp Speed. His task: Overnight success

Moncef Slaoui stepped off Moderna's board of directors on Friday and pivoted straight into the high profile role heading the Trump administration's Project Warp Speed, where he'll be in ...

On May 15, 2020
@BiotechWorld shared
Chutes & Ladders—GSK vaccines vet Slaoui to lead project 'Warp Speed' https://t.co/dVe6OLHvQa https://t.co/TYm81NpVc2
Open

Chutes & Ladders—GSK vaccines vet Slaoui to lead project 'Warp Speed'

Chutes & Ladders—GSK vaccines vet Slaoui to lead project 'Warp Speed'

Trum administration taps Slaoui for "Warp Speed" project; Regev joins Roche; Caribou names Thomas as clinical lead.